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Background: Stenting in small coronary artery and long lesions has been known for high rates of clinical events. There has been no study 
comparing angiographic and long-term clinical outcomes among stable angina patients with sirolimus-(SES,n=285), paclitaxel-(PES,n=52), 
zotarolimus-(ZES,n=93), and everolimus-eluting stent (EES,n=170) implantation in small coronary target vessels and long lesions.
Methods: Propensity matching was performed among 4 cohort groups, and coronary lesions with reference diameter <2.75mm and lesion 
length ≥28mm were included. Late loss and rates of in-stent restenosis at 9-month follow-up were compared, and major adverse cardiovascular 
events(MACEs) such as all-cause death, non-fatal myocardial infarction, stroke, and target lesion revascularization(TLR) were compared during the 
3-year follow-up.
Results: Late loss was significantly lower in the EES group when compared with the PES and ZES groups (0.34±0.14mm, 0.60±0.15mm 
0.65±0.16mm, respectively, P<0.05). Rate of TLR was significantly lower in the in the EES group when compared with the SES, PES and ZES groups 
(2.1%, 9.8%, 11.8%, 8.4%,respectively). Rates of MACE during the 3 year follow-up were significantly lower in the EES group when compared with the 
SES, PES, and ZES groups (4.6%, 13.2%, 14.8%, 11.2%,respectively)(Figure 1).
Conclusions: Rate of MACEs was significantly lower in the EES group when compared with the SES, PES, and ZES groups, mainly due to the lower 
rate of TLR during the 3-year follow-up.
 
